Overview

Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH)

Status:
Recruiting
Trial end date:
2022-07-31
Target enrollment:
Participant gender:
Summary
This study will look at how different single and combination study treatments will work in adults with non-alcoholic fatty liver disease (NAFLD) who have features of non-alcoholic steatohepatitis (NASH). The study will see if the treatments are safe and see if they can improve NAFLD.
Phase:
Phase 2
Details
Lead Sponsor:
Novartis Pharmaceuticals